Beyond hemostasis: a narrative review on the multifaceted therapeutic potential of Ankaferd Blood Stopper
ABS is a promising hemostatic agent with applications in bleeding control, wound healing, and infection management. While it has shown efficacy in various clinical settings, its safety profile remains a subject of debate, with some studies confirming its biocompatibility and others reporting potential neurotoxic effects. Further large-scale human studies are needed to clarify its long-term safety and establish standardized clinical guidelines for its use.
Institutions
- King Edward Medical University (PK)
- Ajman University (AE)
- Trinity School of Medicine (VC)
- Sheba Medical Center (IL)
- Windsor University School of Medicine (KN)
- The University of Texas Rio Grande Valley (US)
- Henry Ford Hospital (US)
- Farooq Hospital (PK)
- Michigan Surgical Hospital (US)
- American University of Antigua (AG)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1097/ms9.0000000000004388
- Primary Topic
- Hemostasis and retained surgical items
- Type
- article
- Field-Weighted Citation Impact
- 0.00